Raising $44 million and taking Mednow public - Karim Nassar

Karim is a deep thinker and I have been lucky to have several insightful conversations with him about all things healthcare. I am excited to share some of these with you. He previously was the CEO and co-founder of Mednow, raising $44 million and taking it public at a $150 million market cap. Correction: Karim meant to say Mckesson acquired Rexall and not RemedyRx Mednow: https://mednow.ca/ Karim: https://x.com/KarimsRealm Rishad: / rishadusmani HealthTech Investors: https://www.healthtechinvestors.com/